Compare ALEMBIC LTD with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SUVEN LIFESCIENCES - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SUVEN LIFESCIENCES ALEMBIC LTD/
SUVEN LIFESCIENCES
 
P/E (TTM) x 67.6 18.4 366.8% View Chart
P/BV x 2.4 3.7 64.3% View Chart
Dividend Yield % 0.4 0.6 75.2%  

Financials

 ALEMBIC LTD   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
SUVEN LIFESCIENCES
Mar-19
ALEMBIC LTD/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs72338 21.3%   
Low Rs34169 20.0%   
Sales per share (Unadj.) Rs4.752.1 9.0%  
Earnings per share (Unadj.) Rs6.16.8 89.4%  
Cash flow per share (Unadj.) Rs6.28.6 72.9%  
Dividends per share (Unadj.) Rs0.201.50 13.3%  
Dividend yield (eoy) %0.40.6 63.8%  
Book value per share (Unadj.) Rs40.765.3 62.3%  
Shares outstanding (eoy) m267.03127.28 209.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.34.9 231.6%   
Avg P/E ratio x8.737.1 23.4%  
P/CF ratio (eoy) x8.529.6 28.7%  
Price / Book Value ratio x1.33.9 33.5%  
Dividend payout %3.322.0 14.9%   
Avg Mkt Cap Rs m14,13932,272 43.8%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m207661 31.4%   
Avg. sales/employee Rs ThNM6,132.2-  
Avg. wages/employee Rs ThNM611.1-  
Avg. net profit/employee Rs ThNM803.5-  
INCOME DATA
Net Sales Rs m1,2556,635 18.9%  
Other income Rs m370242 152.8%   
Total revenues Rs m1,6256,877 23.6%   
Gross profit Rs m1111,604 6.9%  
Depreciation Rs m38221 17.1%   
Interest Rs m238 4.5%   
Profit before tax Rs m4421,587 27.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24718 3.3%   
Profit after tax Rs m1,630869 187.5%  
Gross profit margin %8.924.2 36.6%  
Effective tax rate %5.445.2 12.0%   
Net profit margin %129.813.1 990.9%  
BALANCE SHEET DATA
Current assets Rs m1,8676,232 30.0%   
Current liabilities Rs m5911,490 39.7%   
Net working cap to sales %101.671.5 142.2%  
Current ratio x3.24.2 75.5%  
Inventory Days Days9486 109.1%  
Debtors Days Days7483 89.0%  
Net fixed assets Rs m1,7914,043 44.3%   
Share capital Rs m534127 419.6%   
"Free" reserves Rs m10,3248,183 126.2%   
Net worth Rs m10,8588,310 130.7%   
Long term debt Rs m4118 231.5%   
Total assets Rs m11,59110,389 111.6%  
Interest coverage x260.943.1 605.2%   
Debt to equity ratio x00 177.1%  
Sales to assets ratio x0.10.6 17.0%   
Return on assets %14.18.7 161.2%  
Return on equity %15.010.5 143.5%  
Return on capital %15.219.5 77.8%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m195,622 0.3%   
Fx outflow Rs m2641,799 14.7%   
Net fx Rs m-2443,822 -6.4%   
CASH FLOW
From Operations Rs m236356 66.3%  
From Investments Rs m-224-279 80.4%  
From Financial Activity Rs m-27-225 11.8%  
Net Cashflow Rs m-15-148 10.0%  

Share Holding

Indian Promoters % 64.0 63.4 100.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.5 71.5%  
Shareholders   54,701 37,287 146.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   FULFORD INDIA  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT  SUN PHARMA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Oct 17, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - CIPLA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS